Eko Raises $65M In Series C Round To Expand AI-Based Digital Stethoscope For At-Home Patient Monitoring
Executive Summary
Eko is banking on the growing telehealth market and reimbursement to expand its cardiac care platform.
You may also be interested in...
Fitbit Receives FDA Clearance, CE Mark For ECG App To Rival Apple
Fitbit will launch its new Fitbit Sense smartwatch with ECG app in Europe, US, Hong Kong and India in October.
Telehealth Sees Skyrocketing Demand Amid Regulatory Expansion, Hopes To Last Beyond COVID-19 Crisis
US telehealth companies are seeing skyrocketing demand for devices and services, which offers opportunities and challenges during this COVID-19 crisis.
Eko’s AI Algorithm To Detect Heart Conditions Cleared By US FDA
US regulators have cleared a suite of cloud-based artificial intelligence software intended to be used with Eko’s digital stethoscopes to detect certain heart problems. The company says the AI algorithms are the first of its kind to be cleared by the US FDA.